BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28

• Drug Development

  Peregrine Pharmaceuticals, Inc. Announces Results From Phase II Clinical Trial of Bavituximab in Stage IV Pancreatic Cancer

  February 13, 2013

   · 

  5 min read
• Business

  Swedish Orphan Biovitrum Gains Distribution Rights for Megace®, Monopril®, Cefzil®; and Duricef®; From PharmaSwiss

  February 13, 2013

   · 

  3 min read
• Drug Development

  Auris Medical AG Completes Enrolment in TACTT1 Study With AM-101 for the Treatment of Acute Peripheral Tinnitus

  February 13, 2013

   · 

  2 min read
• Business

  Seattle Genetics, Inc. Reports Fourth Quarter and Year 2012 Financial Results

  February 13, 2013

   · 

  1 min read
• Business

  Fluidigm Corporation Reports Strong Q4 and Full Year 2012

  February 13, 2013

   · 

  1 min read
• Business

  Accelrys Inc. to Announce Fourth Quarter and Full Year 2012 Results on February 26, 2013

  February 13, 2013

   · 

  1 min read
• Business

  Nanobiotix Appoints Dr. Alain Herrera to the Supervisory Board

  February 13, 2013

   · 

  1 min read
• Business

  Acorda Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results

  February 13, 2013

   · 

  1 min read
• Business

  AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) Reports 2012 Financial Results and Highlights Recent Accomplishments

  February 13, 2013

   · 

  1 min read
• Almac Group to Deliver Insight Into Supply Chain Management at Clinical Trial Supply Europe Event

  February 13, 2013

   · 

  1 min read